Vaccines and immunology basics

Immune responses

The immune system uses barriers, innate responses and adaptive responses. Skin and mucous membranes are first barriers. Innate immunity acts quickly and broadly through inflammation, complement, phagocytes and natural killer cells. Adaptive immunity is specific and develops memory. B lymphocytes produce antibodies; T lymphocytes coordinate responses or kill infected cells. An antigen is recognised by immune receptors, while an epitope is a specific part of it.

Primary exposure usually produces a slower response; memory cells support a faster secondary response. Herd or community protection occurs when enough people are immune that transmission is reduced, indirectly protecting some vulnerable people. The threshold varies by pathogen and population mixing; it does not make transmission impossible and is not the same as individual immunity.

Vaccine platforms

Vaccines train immunity without causing the target disease in the usual way. Live attenuated vaccines use weakened organisms; inactivated vaccines use killed organisms; subunit, recombinant and conjugate vaccines use selected components. Viral-vector vaccines deliver genetic instructions through a vector. mRNA vaccines deliver messenger RNA so cells transiently make an antigen; mRNA normally does not alter DNA. Toxoid vaccines target inactivated toxins. Adjuvants strengthen responses.

Boosters may be needed because immunity wanes, pathogens change or initial response is insufficient. Efficacy is performance in study conditions; effectiveness is real-world performance. Vaccines pass phased testing for safety, immunogenicity and efficacy before authorisation, followed by pharmacovigilance. A mild fever can reflect immune activation, but adverse events require investigation rather than automatic assumptions of causation.

India and Prelims

India’s Universal Immunisation Programme targets vaccine-preventable disease. BCG is associated with tuberculosis prevention; oral polio vaccine uses an attenuated virus; hepatitis B vaccines are recombinant in many formulations. Schedules can change, so stable concepts are safer than unverified brand claims. Distinguish antibody from antigen, innate from adaptive, live from inactivated, efficacy from effectiveness, and prevention from antibiotic treatment. A vaccine may reduce severe disease without completely preventing infection or transmission.

Prelims revision checklist

Identify the definition first, then connect it to the relevant institution, date, process and example. Do not treat a scientific mechanism as a policy instrument, an international label as automatic domestic legal status, or a rank as ownership. Watch absolute words such as “always” and “only”; they are rarely correct unless part of a formal definition. In current-affairs questions, apply the stable principle and verify changing figures or variants from an official source.

Additional recall

For elimination, ask what is being measured, who has authority, and whether the statement describes a mechanism, a legal category or an outcome. Similar terms often differ by scope and timing. A precise answer should preserve the distinction between a broad umbrella concept and its narrower operational example.

Analogy

Vaccines and immunology basics — Analogy

A vaccine is an immune rehearsal: it shows a safe practice target so memory cells can respond faster later.